ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
Titel:
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
Auteur:
Oh, Stephen T. Talpaz, Moshe Gerds, Aaron T. Gupta, Vikas Verstovsek, Srdan Mesa, Ruben Miller, Carole B. Rivera, Candido E. Fleischman, Angela G. Goel, Swati Heaney, Mark L. O'Connell, Casey Arcasoy, Murat O. Zhang, Yafeng Kawashima, Jun Ganz, Tomas Kowalski, Mark Brachmann, Carrie Baker